Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network

Background Selective serotonin reuptake inhibitors (SSRIs), such as citalopram, which selectively block serotonin transporter (5-HTT) activity, are widely used in the treatment of depression and anxiety disorders. Numerous neuroimaging studies have examined the effects of SSRIs on emotional processes. However, there are considerable inter-individual differences in SSRI effect, and a recent meta-analysis further revealed discrepant effects of acute SSRI administration on neural responses to negative emotions in healthy adults. Aims We examined how a variant of the serotonin-transporter polymorphism (5-HTTLPR), which affects the expression and function of 5-HTT, influenced the acute effects of an SSRI (citalopram) on emotion-related brain activity in healthy adults. Method Combining genetic neuroimaging, pharmacological technique and a psychological paradigm of emotion recognition, we scanned the short/short (s/s) and long/long (l/l) variants of 5-HTTLPR during perception of fearful, happy and neutral facial expressions after the acute administration of an SSRI (i.e. 30mg citalopram administered orally) or placebo administration. Results We found that 5-HTTLPR modulated the acute effects of citalopram on neural responses to negative emotions. Specifically, relative to placebo, citalopram increased amygdala and insula activity in l/l but not s/s homozygotes during perception of fearful faces. Similar analyses of brain activity in response to happy faces did not show any significant effects. Conclusions Our combined pharmacogenetic and functional imaging results provide a neurogenetic mechanism for discrepant acute effects of SSRIs.

[1]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[2]  Paul J. Harrison,et al.  Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine , 2000, Psychopharmacology.

[3]  Ian M. Anderson,et al.  The effect of acute citalopram on face emotion processing in remitted depression: A pharmacoMRI study , 2011, European Neuropsychopharmacology.

[4]  Y. Ma,et al.  Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis , 2014, Molecular Psychiatry.

[5]  Christian Scharinger,et al.  Imaging genetics: implications for research on variable antidepressant drug response , 2010, Expert review of clinical pharmacology.

[6]  K. Felmingham,et al.  The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: Preliminary findings from a randomised, crossover fMRI study , 2014, The Australian and New Zealand journal of psychiatry.

[7]  R. Elliott,et al.  Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion , 2013, European Neuropsychopharmacology.

[8]  Yoshiro Okubo,et al.  Effects of dopaminergic and serotonergic manipulation on emotional processing: A pharmacological fMRI study , 2005, NeuroImage.

[9]  C. R. Cloninger,et al.  A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.

[10]  Patrick M Fisher,et al.  Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity , 2008, Neuropsychopharmacology.

[11]  P. Cowen,et al.  Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients , 2012, Psychological Medicine.

[12]  P. Nelemans,et al.  Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review , 2004, Molecular Psychiatry.

[13]  D. Perrett,et al.  A differential neural response in the human amygdala to fearful and happy facial expressions , 1996, Nature.

[14]  S. Nanko,et al.  Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder , 1997, Molecular Psychiatry.

[15]  Anil K Malhotra,et al.  Pharmacogenetics of psychotropic drug response. , 2004, The American journal of psychiatry.

[16]  T. Lencz,et al.  Pharmacogenetics in psychiatry: translating research into clinical practice , 2012, Molecular Psychiatry.

[17]  H. Scheinin,et al.  The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system , 2001, Psychopharmacology.

[18]  P. Cowen,et al.  A cognitive neuropsychological model of antidepressant drug action , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  Catherine J. Harmer,et al.  Effect of a single dose of citalopram on amygdala response to emotional faces , 2009, British Journal of Psychiatry.

[20]  Uwe Herwig,et al.  Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants , 2010, Neuropsychopharmacology.

[21]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[22]  A. Simmons,et al.  Anticipation of emotionally aversive visual stimuli activates right insula , 2004, Neuroreport.

[23]  Lutz Jäncke,et al.  Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants , 2011, Psychopharmacology.

[24]  A. Serretti,et al.  Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients , 2007, Molecular Psychiatry.

[25]  M. Frye,et al.  Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder , 2001, Biological Psychiatry.

[26]  R. Weinshilboum.  Inheritance and drug response. , 2003, The New England journal of medicine.

[27]  Jason B. Mattingley,et al.  Methylphenidate But Not Atomoxetine or Citalopram Modulates Inhibitory Control and Response Time Variability , 2011, Biological Psychiatry.

[28]  Luo Yuejia,et al.  Revision of the Chinese Facial Affective Picture System , 2011 .

[29]  Bing Chen,et al.  Pharmacokinetics and Bioavailability Comparison of Generic and Branded Citalopram 20 mg Tablets , 2012, Clinical Drug Investigation.

[30]  A. Simmons,et al.  Escitalopram effects on insula and amygdala BOLD activation during emotional processing , 2008, Psychopharmacology.

[31]  David Taylor,et al.  The adverse effects of antidepressants , 1997 .

[32]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[33]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[34]  Rebecca Elliott,et al.  The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study , 2005, Neuropsychopharmacology.

[35]  P. Cowen,et al.  The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis , 2013, Molecular Psychiatry.

[36]  Michael F Egan,et al.  A susceptibility gene for affective disorders and the response of the human amygdala. , 2005, Archives of general psychiatry.

[37]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[38]  C. Grady,et al.  Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks , 2013, European Neuropsychopharmacology.

[39]  Ahmad R. Hariri,et al.  Serotonin Transporter Genotype (5-HTTLPR): Effects of Neutral and Undefined Conditions on Amygdala Activation , 2007, Biological Psychiatry.

[40]  A. Craig.  How do you feel? Interoception: the sense of the physiological condition of the body , 2002, Nature Reviews Neuroscience.

[41]  A. Simmons,et al.  Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers. , 2009, The international journal of neuropsychopharmacology.

[42]  K. Lesch,et al.  Long story short: the serotonin transporter in emotion regulation and social cognition , 2007, Nature Neuroscience.

[43]  H. Wikström,et al.  Acute and chronic effects of citalopram on postsynaptic 5‐hydroxytryptamine1A receptor‐mediated feedback: a microdialysis study in the amygdala , 2001, Journal of neurochemistry.

[44]  P. Cowen,et al.  Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action , 2009, British Journal of Psychiatry.

[45]  N. Freemantle,et al.  Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. , 2006, Archives of general psychiatry.

[46]  E. Smeraldi,et al.  Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine , 1998, Molecular Psychiatry.

[47]  R. Elliott,et al.  Neuronal effects of acute citalopram detected by pharmacoMRI , 2005, Psychopharmacology.

[48]  Rebecca Elliott,et al.  Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study , 2007, Neuroreport.

[49]  K. Felmingham,et al.  Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women. , 2014, Journal of psychiatry & neuroscience : JPN.

[50]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[51]  Luke Clark,et al.  Serotonin selectively influences moral judgment and behavior through effects on harm aversion , 2010, Proceedings of the National Academy of Sciences.